Loading market dashboard
Evaxion Biotech A/S
EVAXHealthcareNASDAQDK
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Evaxion Biotech A/S · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $29.14M | $29.14M - $29.14M | -$5.52M | -$0.01 | 1 |
| Dec 2029 | $72.65M | $72.65M - $72.65M | -$13.75M | $0.08 | 2 |
| Dec 2028 | $24.04M | $24.04M - $24.04M | -$4.55M | $0.005 | 3 |
| Dec 2027 | $22.60M | $22.60M - $22.60M | -$4.28M | $0.04 | 3 |
| Dec 2026 | $5.27M | $5.27M - $5.27M | -$996.8K | -$0.025 | 2 |
| Dec 2025 | $7.51M | $7.51M - $7.51M | -$1.42M | -$0.45 | 2 |
| Dec 2024 | $4.48M | $3.24M - $5.71M | -$848.0K | -$4.08 | 2 |
| Dec 2023 | $278.0K | $278.0K - $278.0K | -$52.6K | -$3.782 | 1 |